Inflammatory skin and bowel disease linked to ADAM17 deletion

N Engl J Med. 2011 Oct 20;365(16):1502-8. doi: 10.1056/NEJMoa1100721.

Abstract

We performed genetic and immunohistochemical studies in a sister and brother with autosomal recessive neonatal inflammatory skin and bowel lesions. The girl died suddenly at 12 years of age from parvovirus B19-associated myocarditis; her brother had mild cardiomyopathy. We identified a loss-of-function mutation in ADAM17, which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis factor α [TNF-α]-converting enzyme, or TACE), as the probable cause of this syndrome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 17 years of age showed high levels of lipopolysaccharide-induced production of interleukin-1β and interleukin-6 but impaired release of TNF-α. Despite repeated skin infections, this young man has led a relatively normal life. (Funded by Barts and the London Charity and the European Commission Seventh Framework Programme.).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / genetics*
  • ADAM17 Protein
  • Adolescent
  • Child
  • Fatal Outcome
  • Female
  • Humans
  • Inflammatory Bowel Diseases / genetics*
  • Male
  • Myocarditis / genetics
  • Myocarditis / virology
  • Pedigree
  • Sequence Deletion*
  • Skin Diseases / genetics*

Substances

  • ADAM Proteins
  • ADAM17 Protein
  • ADAM17 protein, human